Publication date: Jun 06, 2025
RNA viruses like SARS-CoV-2 have high mutation rates, which contribute to their rapid evolution. Mutation rates depend on mutation type and can vary between sites in a virus’s genome. Understanding this variation can shed light on the mutational processes at play, and is crucial for quantitative modeling of viral evolution. Using millions of SARS-CoV-2 full-genome sequences, we estimate rates of synonymous mutations for each mutation type and examine how much these rates vary between sites. We find a surprisingly high level of variability. A substantial fraction of this variability can be explained by local sequence context, genomic region, and RNA secondary structure. We estimate fitness effects of each mutation based on the number of times it actually occurs versus the number of times it is expected to occur based on a model of the above features. We identify small regions of the genome where synonymous or noncoding mutations occur much less often than expected, indicative of strong purifying selection on the RNA sequence independent of protein sequence. Overall, this work expands our basic understanding of SARS-CoV-2’s evolution by characterizing the virus’s mutation process at the level of individual sites and uncovering several striking mutational patterns that arise from unknown mechanisms.
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | mutation rate |
disease | IDO | protein |
disease | IDO | process |
drug | DRUGBANK | Coenzyme M |
pathway | REACTOME | Reproduction |
drug | DRUGBANK | Hexocyclium |
disease | IDO | host |
disease | MESH | oxidative damage |
disease | IDO | site |
disease | IDO | history |
drug | DRUGBANK | Amino acids |
drug | DRUGBANK | Acetylcholine |
disease | IDO | quality |
drug | DRUGBANK | Aspartame |
disease | MESH | uncertainty |
drug | DRUGBANK | Ilex paraguariensis leaf |
drug | DRUGBANK | Piroxicam |
drug | DRUGBANK | L-Valine |
disease | IDO | replication |
drug | DRUGBANK | Trestolone |
drug | DRUGBANK | Esomeprazole |
pathway | KEGG | Viral replication |
pathway | REACTOME | Translation |
drug | DRUGBANK | Pentaerythritol tetranitrate |
drug | DRUGBANK | Stavudine |
drug | DRUGBANK | Fenamole |
disease | MESH | infection transmission |
disease | MESH | COVID 19 pandemic |
disease | IDO | cell |
drug | DRUGBANK | Flunarizine |
pathway | KEGG | Ribosome |
drug | DRUGBANK | Alprostadil |
disease | IDO | nucleic acid |